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Summary 
~" and r/chains of the T  cell antigen receptor (TCR) complex and the y  chain of Fc receptors 
(FcRy) constitute a family of proteins important for the expression of, and signal transduction 
through, these receptors in hematopoietic cells. In ~'-deficient mice, TCR expression was reduced 
in most T cells. By contrast, CD8oto~  + TCR-~//5 + intestinal intraepithelial lymphocytes in these 
mice expressed a normal level of TCR. Biochemical analysis of the TCR complex in these cells 
from ~'-deficient as well as normal mice revealed the predominant usage of FcRy. Furthermore, 
y/5 + T  cells in epithelia of the skin and female reproductive organs from g'-deficient mice also 
showed relatively high  TCR  expression,  indicating the usage of FcRq/.  These observations 
demonstrate the preferential usage of FcR3' by 3'/c5 § T cells localized in epithelia of normal mice. 
T  cells recognize antigen bound to the products of MHC 
on APC through TCR, and are activated to exert var- 
ious effector functions (1, 2). The TCR complex is a multi- 
meric complex composed of three groups of proteins;  the 
TCR-c~/fl  (or -y/5)  dimer, the CD3 complex, and the ~" 
family of disulfide-linked dimers (3). TCR dimers are respon- 
sible for antigen binding, whereas the other molecules are 
thought to be important for transmembrane signaling. 
The ~" family has three known members, g', ~/, and FcR~/ 
(4-6).  In thymocytes and peripheral T  cells, most of TCR 
complexes contain ~-homodimers, whereas 5-10% of TCRs 
associate with the g'-7/heterodimer. On the other hand, the 
TCR complex in a minor population of T  cells has ~" and 
~/as a form of heterodimers with FcRy (4,  5).  Moreover, 
it is reported that FcR3' was exclusively associated with TCR 
in in vitro cultured large granular lymphocytes (6). 
A considerable body of evidence shows the importance of 
~'both in assembly and surface expression of the TCR com- 
plex and in receptor-mediated signal transduction (7-13).  Cy- 
toplasmic tails of ~" family as well as CD3 molecules have 
consensus motifs important for intracellular signal transduc- 
tion (14, 15). Recent studies indicate that the TCR complex 
has two signal transduction modules, the ~" family dimer and 
the CD3 complex, and that the two modules could trans- 
duce distinct signals  into the cells (15,  16).  In addition, it 
has been reported that the TCR complex containing FcR3' 
has a different signaling capacity from those containing ~" 
(17-19).  Consequently, differential usage of ~" family mole- 
cules by distinct subsets  of T  cells may reflect difference in 
lineage and/or function of these cells. 
Recently, we and others demonstrated that ~" is critical for 
normal T cell development and function, using mice deficient 
in the expression of ~" (20,  21).  We also showed that ~  is 
not so efficient in assembly and surface expression of TCR 
complexes as ~" (20).  Biochemical analysis of T  hybridoma 
ceils revealed  that  this was caused by retention in the en- 
doplasmic reticulum of q-containing TCR complexes (22). 
Taking advantage of the mice lacking ~" (sr'T/~'T mice) (20), 
we evaluated FcRy usage by various subsets of T  cells. 
Materials and Methods 
Mice.  C57BL/6 and KSN nu/nu mice (23) were purchased from 
Japan SLC, Inc. (Hamamatsu, Japan). ~q" mice (20) were bred in 
our facility. 
Cell Preparation.  Single cell suspensions of thymocytes and 
splenocytes  were prepared in RPMI 1640 supplemented with 10% 
heat-inactivated FCS, 2 mM glutamine,  50/xM 2-ME, and 100 
#g/mI kanamycin. Splenocytes were depleted of erythrocytes by 
lysis. For enrichment of CD4-8-  double-negative (DN) thymo- 
cytes, thymocytes were incubated with culture supernatant of anti- 
CD4 mAb (MT4), plated on plastic dishes precoated with rabbit 
anti-mouse immunoglobulin  (Cappel Laboratories, Cochranville, 
PA),  and  nonadherent  cells were  collected  as  DN  thymo- 
cytes-enriched population.  Intestinal intraepithelial lymphocytes 
(i-IEL), hepatic lymphocytes, lymphocytes in mucosal epithelia of 
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Figure  1.  Expression  ofTCR-cdB and-'y/8 
dimers on thymocytes, splenocytes,  and i-IEL 
from ffr/~'T mice. (.4) CD3e and TCR/3 or 
TCR8 expression  on the surface  of thymocytes, 
splenocytes, and i-IEL were examined as de- 
scribed in Materials and Methods. (B) CD4, 
CD8, and TCR(5 expression on the surface of 
i-IEL were analyzed. CD4/CDfc~ or CDfc~/ 
CDf/~ were used to divide  i-IEL into four sub- 
populations (top). The histograms shown  below 
represent the fluorescence  intensity for TCR-(5 
detected  by the third fluorescence,  within each 
quadrant. 
the  female  reproductive  tract  (r-IEL),  and  Thy-1 +  dendritic 
epidermal T  cells (DETC) were isolated  as previously described 
(24-27). 
Flow Cytometric Analysis.  Cells from the thymus, spleen, pe- 
ripheral blood, liver, i-IEL, DETC, and r-IEL were stained  with 
mAbs recognizing CD3e,  TCR-c~//~,  TCR-y/(5, CD4,  CD8c~, 
CD8/~,  and IL-2R/3, and the surface expression of these molecules 
was analyzed on a FACScan |  flow cytometer (Becton Dickinson 
& Co., Mountain View, CA). The following mAbs were used: PE- 
conjugated anti-CD4 (GK1.5) and FITC-labeled anti-CD8c~  (53- 
6.7), purchased from Becton Dickinson & Co., FITC-conjugated 
or biotinylated anti-CD3e  (145-2Cll);  biotinylated anti-TCR-/~ 
(H57-597), biotinylated anti-TCR-y/~i (GL3); and PE-labeled anti- 
CD45R/B220 (RA3-6B2) from PharMingen (San Diego, CA); bi- 
otinylated anti-IL-2R~ (TM-/31) was kindly provided by Dr. M. 
Miyasaka (Tokyo Metropolitan Institute of Medical Science, Tokyo, 
Japan).  Biotinylated mAbs were developed with streptavidin-PE 
(Becton Dickinson & Co.) or streptavidin-Tri-Color  |  (Caltag Labora- 
tories,  San Francisco,  CA). Dead cells were excluded by staining 
with propidium iodide.  Cells in the lymphocyte gate defined by 
light scatter were collected. 
Cell Surface  Biotinylation, Immunoprecipitation,  and Two-dimensional 
SDS-PAGE Analysis.  Cell surface biotinylation was performed as 
previously described (28). Cells were then solubilized in lysis buffer 
(1% digitonin, 50 mM Tris-HC1, pH 7.6,300 mM NaC1, 10/~g/ml 
aprotinin, 10/xg/ml leupeptin,  1 mM PMSF,  10 mM iodoaceta- 
mide) at a concentration of 10  s cells/ml.  Immunoprecipitation was 
performed with anti-TCR-~ mAb (3A10), anti-TCR-/~ mAb (H57- 
597), anti-~"  mAb (H146.698-A),  and anti-FcR'y antiserum, which 
were kindly provided by Drs. S. Tonegawa  (Massachusetts  Insti- 
tute of Technology, Boston, MA), R. Kubo (Cytel Corporation, 
San Diego, CA), and C. Ra (Juntendo University, Tokyo, Japan), 
respectively. Immunoprecipitates were resolved by two-dimensional 
nonreducing-reducing SDS-PAGE (14% for the first dimension and 
16% for the second dimension), transferred onto polyvinylidene 
fluoride membrane (Immobirom-P~;  Millipore Corp.,  Bedford, 
MA). Membranes were soaked in skim-milk in PBS, and biotinylated 
proteins  were  detected  using  streptavidin-peroxidase  (VECTA- 
STAIN |  Elite ABC kit; Vector Laboratories Inc., Burlingame,  CA) 
and ECL  |  system (Amersham International, Buckinghamshire, 
England). 
Results and Discussion 
The expression levels of TCR on thymocytes and periph- 
eral T  cells were significantly reduced in s~T/sr'I  ' mice (20). 
366  Differential  Usage of ~" Family Dimers by Different T Cell Subsets Figure  2.  Biochemical  analysis  of the surface  TCR composition. 
(A) Total and (B) DN-enriched thymocytes  from wild type mice, 
i-IEL from (C and D) C57BL/6 (+/+) mice, (E) KSN nu/nu mice, 
and (F) ~'T/~'T  mice  were surface  biotinylated,  lysed,  and the TCR. 
complex  was immunoprecipitated  with (A and C) anti-TCR-/~  mAB 
(H57-597), or B, D,  E,  and F) anti-TCR-8 mAb (3A10). Im- 
munoprecipitates were separated  by two-dimensional  nonreducing- 
reducing SDS-PAGE, transferred onto PVDF membrane, and bi- 
otinylated proteins were detected as described in Materials and 
Methods. Positions  of ~'-~"  (t), ]'-FcR~ ( i ), and FcRT-FcR7 (A) 
dlmers  are indicated.  Note  that  heterodimers  of  1,12 (35. and Kuwabara, 
I., and Saito, T., manuscript in preparation) with ~" and FcR  7 are 
observed in some  panels. In three experiments (including  E), den- 
sitometric analysis  showed that the mean of the FcR7 of ~'-FcR7 
dimers/FcR3,  of FcRT-FcR.  Y  dimers  is 1:11.9. Considering  that the 
molar ratio of ~" and FcR7 in ~'-FcR7 dimers is 1, the expression 
level of FcR7 molecules is 13 times more than that of ~'. 
This was observed in both oe/3 + and 3,/8 + thymocytes as 
well as splenic T  cells (Fig.  1 A). These data indicate that 
those cells predominantly express  ~" as a component of the 
TCR complex, and extended to normal T cells the previous 
observation on in vitro cell lines that the expression  of ~" is 
critical for a normal level of surface TCR expression  (7-10). 
When we analyzed i-IEL, however,  a striking difference 
was observed (Fig. 1 A) (20). Similar to thymocytes and pe- 
ripheral T cells, surface TCR expression of oe/3 + i-IEL was 
impaired by the ~'T mutation. By contrast, surface TCR. level 
of 9//8 + i-IEL from ~'T/~'T mice was comparable with that 
of 9//8 + i-IEL from wild type mice. In 9//8 + i-IEL, two dis- 
tinct subpopulations are known;  the major population of 
CD8~oe-bearing cells and the minor DN cells. The former 
is thought to differentiate extrathymicaUy, whereas the latter 
is believed to derive from the thymus (29).  Whether TCR 
expression of both 7/8 + i-IEL populations was resistant to 
the ~'T mutation was analyzed by three-color flow cytom- 
etry. As shown in Fig.  1 B, the expression level of surface 
TCR in CD8otot + 9/18 + i-IEL from ~'T/~'T mice remained 
normal, but  that in DN  9//8 + i-IEL was reduced.  These 
observations  suggest that, in CD8otc~  + 3,/8 §  i-IEL, ~" family 
molecules  other  than  ~"  were  predominantly  associated 
with TCR.. 
To test this possibility, various preparations of T cells were 
analyzed for their composition of TCR complexes by a sen- 
sitive  surface biotinylation (28)  and two-dimensional non- 
reducing-reducing SDS-PAGE.  TCR  on  ol/3 +  and 718 + 
thymocytes as well as c~/B + i-IEL from wild type mice was 
predominantly associated with ~'-~"  homodimers (Fig. 2, A-C). 
By contrast, analysis of TCR complexes  on 7/8 + i-IEL re- 
vealed that, on these cells, both ~" and FcR3, contribute for 
TCR constitution (Fig. 2 D). Identification of ~" and FcR9/ 
was confirmed by direct precipitation of  these molecules with 
anti-~"  mAb (H146.968A) and anti-FcR3" antiserum, respec- 
tively (data not shown). Existence of two subpopulations in 
7/8 +  i-IEL  from  normal  mice  as  mentioned above  may 
complicate the analysis. To avoid this complexity, we utilized 
3,/8 + i-IEL from nude mice, which consist exclusively  of 
CD8olo~  + cells (Ohno, H., unpublished observation). The 
result was more striking; these cells predominantly utilize 
FcR7 as TCR subunits, and ~"  homodimers were hardly seen 
(Fig.  2 E).  Assuming that the labeling efficiency of FcR3" 
is comparable between FcR9/homodimers and FcRT-~" het- 
erodimers, these cells express 13 times more FcR7 molecules 
than ~- in TCR (see legend to Fig. 2).  It is likely that DN 
718 + i-IEL, like 718 + thymocytes, predominantly utilize ~" 
based on the following reasons:  the amount of precipitated 
~" from 7/8 + i-IEL from normal mice was much higher than 
that from nude mice;  and TCI~ expression  in DN  3,/8 + 
i-IEL from ~'T/~'T mice was reduced. We further examined 
whether  the  predominance  of FcR3,  in  CD8oeot +  3,/8 + 
i-IEL is also observed  in ~'T/~'T mice. Fig. 2 F  shows that 
this was the case. Collectively, these data indicate that the 
normal level of TCR expression  in CD8oe~ + 3,/8 +  i-IEL 
from ~'T/~'T mice correlates the predominant usage of FcR3, 
by TCR in this subset. 
The preferential usage of FcR3, as a TCR component in 
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Figure  3.  Expression  of TCR on hepatic lymphocytes,  r-IEL, and DETC 
from ~T/~T mice. (A) CD3e and IL-2R3 expression on hepatic lympho- 
cytes was analyzed as described  in Materials and Methods. CD3i.qL-2R3  hi 
cells, which are thought to develop  extrathymically in the liver (30), are 
indicated with squares. (B) CD3E and TCR(5 expression  on peripheral blood 
cells, r-IEL, and DETC were examined as described in Materials and 
Methods. 
CD8otcr + TCR 3,/(5 + i-IEL propelled us to analyze other 
T cell subsets for their usage of FcR3,. For this purpose, we 
examined the expression levels of TCR in T cells from ~'T/s~'T 
mice and compared them with those in T  cells from wild 
type mice. Since r/is far less efficient in assembly and surface 
expression of TCR compared with  ~" (20, 22), it is reason- 
able to assume that T  cells whose TCR expression is resis- 
tant to the ~'T mutation utilize FcR3' as a component of the 
TCR complex. Similar to thymocytes and peripheral T cells, 
TCR on CD3inqL-2R3 hi hepatic lymphocytes (30) were re- 
duced in ~'T/~'T mice (Fig.  3 A). By contrast,  surface TCR 
expression of r-IEL and DETC from ~'T/~'T mice remained 
higher than that of peripheral T cells, indicating the predom- 
inant  usage of FcR7 in  these cells  (Fig.  3 B). 
The present study demonstrates that in mice, certain subsets 
of T cells preferentially utilize FcR3,, of ~" family molecules, 
as  a  component  of  the  TCR  complex.  These  include 
CD8oec~ + 3,/8 + i-IEL, r-IEL, and DETC.  It is of note that 
all these T  cells express the TCR-y/5 dimer and are local- 
ized in epithelia. In addition, these cells express a higher level 
of TCR compared with peripheral T cells. These three subsets 
of y/8+  T  cells  are thought  to be phylogenically old and 
to play a part  in the surveillance of body surfaces  that  are 
exposed to the environment  (26, 31, 32). In this respect, it 
is of particular interest that these T  cells commonly utilize 
FcRy as a component of their TCR complexes. FcR'y has 
one signaling  motif in the cytoplasmic portion,  whereas ~" 
has three motifs, which are supposed to be generated by in- 
tramolecular duplication. Furthermore, FcR3, is also expressed 
in NK cells, which are proposed to be the ancestor of T cells 
(33). Taken together,  FcR3~ may be a prototype of ~" family 
molecules. 
Differential usage of ~" and FcR'y by distinct T cell subsets 
likely represents  differences in lineage and/or function of these 
cells. Recently, evidence supporting the idea that TCR with 
FcRy is functionally distinct from TCR with ~" is increasing. 
First,  in vitro kinase assay on immunoprecipitates  of TCR 
complexes containing FcR3~ displayed a distinct phosphory- 
lation pattern from that of TCR complexes containing ~" in 
T hybridoma cells (17). Second, the cytoplasmic tail of ~'but 
not FcR  3, can transduce signals mediated through Thy-1 mol- 
ecules (18). Third, ~'is replaced by FcR3, in T cells from tumor- 
bearing mice as well as cancer patients,  and  the change is 
accompanied with immune incompetence including an im- 
paired antitumor  response (19).  Concerning  the functional 
difference between distinct T  cell subsets, an interesting re- 
sult was reported  in  mucosal immunity  (34);  y/8+  i-IEL 
from mice orally immunized  with antigen  abrogates toler- 
ance induced in recipient mice by oral administration  of the 
same antigen when transferred, while ot/3 + i-IEL provides 
helper function for antibody production in vitro. These func- 
tional  differences may reflect differential usage of ~" family 
molecules by "y/8+ and ot/fl + i-IEL.  Further study should 
shed light on the physiological role ofT cell subsets bearing 
TCR with different  ~" family molecules. 
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Note Added in Proof: After submitting  this paper, Malissen et aI. (36) reported a similar observation that 
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